PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1935215
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1935215
Balloon Catheters Market is estimated to be valued at USD 4,443.6 Mn in 2026 and is expected to reach USD 6,689 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4,443.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.30% | 2033 Value Projection: | USD 6,689 Mn |
The balloon catheter is a flexible, tubular device with a balloon at its tip that is used to create, enlarge or remove blockage of a passageway within the body, by passing it through body channels. The balloon tip can be expanded by water or air to remove the blockage or to expand partly closed passageway during surgical procedure. The balloon catheter is used to treat heart related disease such as coronary heart disease, which are caused due to diabetes, high blood pressure, and high cholesterol level in blood. During the treatment of coronary heart disease, the balloon catheter helps to allow the blood flow from arteries by making a passageway, blocked due to excess cholesterol, avoiding open heart surgery.
Moreover, the balloon catheter plays a major role in angioplasty to treat atherosclerosis by widening the narrowed or obstructed arteries or veins. As, the procedure is minimally invasive, it is economically beneficial to the patient and helps patient to get cure rapidly as compared to open surgical procedure.
Rising incidence of coronary heart disease cases due to increasing prevalence of diabetes, high blood pressure cases, and increasing number of smokers across the globe is expected to drive demand for balloon catheters over the forecast period. For instance, according to the World Health Organization (WHO), in 2017 around 17.9 million death cases were reported globally due to cardiovascular disease.
Moreover, product launches by key players is expected to drive the balloon catheters market growth over the forecast period. For instance, in September 2018, SIS Medical, a Switzerland-based manufacturer of innovative cardiology products launched three models of its balloon catheters, EasyT, NIC 1.1 hydro, and NIC Nano hydro. The novel balloon catheters are used in interventional cardiology to dilate narrowed and closed heart vessels. Furthermore, in 2019, the company received CE marking for these products to be marketed in Europe. The company is also planning to facilitate the registration of these products in Asia Pacific, Latin America, and few Middle East countries.
Thus, rising prevalence of coronary heart disease is expected to provide a favorable opportunity for key players to develop and launch innovative balloon catheters to use during interventional cardiology services, which is expected to drive the global balloon catheters market growth over the forecast period.
Key features of the study